ESTUDIO OBSERVACIONAL RETROSPECTIVO PARA DETERMINAR EL ESTADO DE RIESGO DE PACIENTES CON HIPERTENSIÓN ARTERIAL PULMONAR EN ESPAÑA. SEMÁFORO.

Dades bàsiques

Protocol:
ACT-HAP-2017-01
EURDRACT:
NCT:
Centre:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Any inici:
2018
Any de finalització:
ESTUDIO OBSERVACIONAL INTERNACIONAL

Objectius del projecte

Observaciones: Estado Comité: ACTIVO

Documents

  • No hi ha documents

Participants

Grups d'Investigació

Finançadors - Promotors

ACTELION PHARMACEUTICALS ESPAÑA

Resultats de l'Assaig Clínic


Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism.

Kuperman, A; (...); RIETE Investigators

Article. 10.1007/s11239-018-1610-9. 2018


Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis.

Candeloro, Matteo; (...); Di Nisio, Marcello

Article. 10.1182/bloodadvances.2022007961. 2022

  • Open Access.

Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism

Brenner, B; (...); RIETE Investigators

Article. 10.1016/j.amjmed.2018.04.037. 2018


Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism.

Ruiz-Artacho, Pedro; (...); The Riete Investigators

Article. 10.3390/cancers14174127. 2022

  • Open Access.

Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach.

García-Ortega A; (...); Martínez-García MÁ

Review. 10.21037/jtd-20-3062. 2021

  • Open Access.

Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years.

Jara-Palomares L; (...); RIETE investigators

Article. 10.1038/s41598-019-55213-8. 2019

  • Open Access.

Correlation between short-term air pollution exposure and unprovoked lung embolism. Prospective observational (Contamina-TEP Group)

de Miguel-Diez, J; (...); Jara-Palomares, L

Article. 10.1016/j.thromres.2020.04.033. 2020


Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].

Trujillo-Santos, Javier; (...); Monreal, Manuel

Correction. 10.1016/j.thromres.2021.10.019. 2021

  • Open Access.

Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].

Trujillo-Santos J; (...); RIETE Investigators

Correction. 10.1016/j.thromres.2020.10.001. 2020

  • Open Access.

Changes in sleep-disordered breathing from the acute to the stable phase of pulmonary embolism and impact of right ventricular dysfunction: preliminary findings of ESAET study

Ortega, AG; (...); Martinez-Garcia, MA

Meeting Abstract. 10.1183/13993003.congress-2020.4974. 2020


Chronic thromboembolic pulmonary hypertension in Spain: a decade of change.

Martinez-Santos, Paula; (...); Escribano-Subias, Pilar

Article. 10.1016/j.recesp.2020.05.037. 2020


Diagnostic yield of targeted next generation sequencing panel in pulmonary arterial hypertension and veno-occlusive disease according to the age at diagnosis

Chaverri, AR; (...); Subias, PE

Meeting Abstract. 2018


Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model.

Jimenez, David; (...); Lobo, Jose Luis

Article. 10.3389/fcvm.2022.872115. 2022

  • Open Access.

From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?

Martínez Meñaca A; (...); Escribano Subías P

Article. 10.1007/s12325-021-01625-w. 2021


Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations

Barbera, JA; (...); Escribano, P

Article. 10.1016/j.arbres.2017.11.014. 2018


Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism.

Jaureguizar, Ana; (...); Registro Informatizado de la Enfermedad TromboEmbolica Investigators

Article. 10.1016/j.chest.2021.08.059. 2021


IMPACT OF PULMONARY ARTERIAL HYPERTENSION WITH OR WITHOUT INTERSTITIAL LUNG DISEASE ON SCLERODERMA: A RETROSPECTIVE COHORT STUDY FROM THE NATIONWIDE SPANISH SCLERODERMA (RESCLE) AND PULMONARY ARTERIAL HYPERTENSION (REHAP) REGISTRIES

Guillen-del-Castillo, A.; (...); Simeon-Aznar, C. P.

Meeting Abstract. 10.1136/annrheumdis-2020-eular.4302. 2020

  • Open Access.

Impact of the alveolar-arterial oxygen gradient on prognosis after liver transplantation in adults: a single-center experience

Ortega, AG; (...); Reyes, RL

Meeting Abstract. 10.1183/13993003.congress-2020.1917. 2020


Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.

García-Ortega A; (...); Martínez-García MÁ

Article. 10.1016/j.jinf.2021.01.003. 2021

  • Open Access.

Inter-observer correlation in detection of pulmonary hypertension (PH) after an acute pulmonary embolism (PE)

Chasco Eguilaz, Leyre; (...); Sanchez Diaz, Jose Maria

Meeting Abstract. 10.1183/13993003.congress-2019.PA1446. 2019


Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19

Bekki, Amina; (...); Angel Martinez-Garcia, Miguel

Meeting Abstract. 10.1183/13993003.congress-2021.OA2597. 2021


Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.

Riera-Mestre A; (...); Monreal M

Article. 10.1186/s13023-019-1172-8. 2019

  • Open Access.

Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications.

García-Ortega A; (...); Martínez-García MÁ

Article. 10.1183/13993003.00893-2018. 2019

  • Open Access.

Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders

Velasco, D; (...); RIETE Investigators

Article. 10.1016/j.thromres.2020.05.052. 2020


Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders

Velasco Alvarez, Diurbis Josefina; (...); Jimenez Castro, David

Meeting Abstract. 10.1183/13993003.congress-2020.4973. 2020


Portopulmonary hypertension: prognosis and management in the current treatment era. Results from the REHAP Registry.

Lázaro Salvador M; (...); Escribano Subías P

Article. 10.1111/imj.14751. 2020


Predictors of Early Mortality in Cancer-Associated Thrombosis: Analysis of the RIETE Database.

Tafur AJ; (...); Monreal M

Article. 10.1055/s-0038-1642022. 2018

  • Open Access.

Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19.

Fernández-Capitán C; (...); Monreal M

Article. 10.1055/s-0040-1718402. 2020

  • Open Access.

Pretriscuspid shunt and Eisenmenger syndrome: a deadly combination

Escribano, JP; (...); Subias, PE

Meeting Abstract. 2020


Prevalence of obstructive sleep apnea in acute phase of pulmonary embolism: Preliminary results of ESAET study

Yepez, GJO; (...); Garcia, MAM

Meeting Abstract. 10.1183/13993003.congress-2020.2505. 2020


Pulmonary venous thrombosis secondary to radiofrequency ablation of the pulmonary veins.

Lopez-Reyes, R; (...); Nauffal, D

Article. 10.1016/j.rmcr.2017.11.008. 2018

  • Open Access.

Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism.

Jimenez, David; (...); IPEP investigators

Article. 10.1183/13993003.00412-2021. 2021


Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry.

Del Pozo R; (...); REHAP investigators

Article. 10.1016/j.ijcard.2018.10.012. 2019


Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)

Martinez Menaca, Amaya; (...); Lopez Reyes, Raquel

Meeting Abstract. 10.1183/13993003.congress-2019.PA1442. 2019


Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Spyropoulos, AC; (...); MARINER Investigators

Article. 10.1056/NEJMoa1805090. 2018

  • Open Access.

Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism

Trujillo-Santosa, J; (...); RIETE Investigators

Article. 10.1016/j.thromres.2020.06.035. 2020


Sex Differences in Patients With Occult Cancer After Venous Thromboembolism

Jara-Palomares, L; (...); Monreal, M

Article. 10.1177/1076029617711805. 2018

  • Open Access.

The importance of comorbidities in idiopathic and associated with connective tissue disease pulmonary arterial hypertension: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)

Bravo-Marques, R.; (...); Escribano-Subias, P.

Meeting Abstract. 2024


The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism.

Duran, Diego; (...); Jimenez, David

Article. 10.1016/j.ahj.2022.11.017. 2022


Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach.

López-Reyes R; (...); García-Ortega A

Review. 10.1016/j.arbres.2020.07.033. 2021

  • Open Access.

Use and results of fibrinolysis in pulmonary embolism. Experience in a tertiary hospital.

Torrents Vilar, Ana; (...); Lopez Reyes, Raquel

Meeting Abstract. 10.1183/13993003.congress-2018.PA3123. 2018


Use of Long-term Oxygen Therapy in Patients With Pulmonary Hypertension in Spain

Blanco, I.; (...); Barbera, J. A.

Meeting Abstract. 2023


Venous thromboembolism in solid-organ transplant recipients: findings from the RIETE registry

Ortega, AG; (...); Monreal, M

Meeting Abstract. 10.1183/13993003.congress-2020.3571. 2020


Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.

Garcia-Ortega, Alberto; (...); RIETE Investigators

Article. 10.1016/j.thromres.2021.02.022. 2021


Campos d'Estudi

Compartir el projecte